Motley Rice - Attorneys at Law
Navigation
Main navigation
Motley Rice represents clients across many areas.
Learn about the cases Motley Rice is actively representing clients in or cases that we've litigated previously.
Ozempic® users are filing lawsuits for vision loss, ileus, and other serious injuries.
Lawsuits allege talcum powder use is linked to reproductive organ cancer for women.
Lawsuits allege toxic heavy metals in baby food damage infants’ brain development.
Social media companies are being sued over alleged teenage mental health harms.
Meta is being sued for teenage mental health harms allegedly caused by Facebook and Instagram.
Women hurt by birth control drugs and devices may be eligible to sue over their injuries.
Studies link hair relaxers to uterine/ovarian cancer. Lawsuits seek to hold companies accountable.
Family members may have been eligible to file Camp Lejeune water contamination lawsuits.
People are filing gastroparesis lawsuits after using drugs like Ozempic®, Wegovy® and Mounjaro™.
While litigation can take years to complete from start to finish, our firm is always working for our clients, no matter how long it takes or how hard it gets.
Motley Rice attorneys and support personnel are dedicated to representing clients and working with co-counsel located throughout the United States and around the world.
Comprehensive, up-to-date news on the issues surrounding the litigation areas of Motley Rice LLC.
News, Learn about the latest happenings from lawsuits and other events impacting plaintiffs.
Motley Rice lawyers share their insights on litigation and more to inform people exploring their legal options.
We are accepting new cases
E-cigarette Antitrust Lawsuits
The Legal Team
JUUL quickly grew into the nation’s largest e-cigarette manufacturer within a few short years of its 2015 launch. The company is now facing allegations that it and global cigarette manufacturer Altria Group, Inc., engaged in illegal, anticompetitive behavior to boost e-cigarette sales and tighten JUUL’s stronghold on the industry.
Wondering what happens when you submit a form or give us a call? We spend time gathering information from you, and your initial call is always free.
or call: 1.800.768.4026
Aug. 19, 2021
The Direct Purchaser Plaintiffs’ allege JUUL schemed with global cigarette manufacturer Altria Group, Inc. to tighten its grip on the e-cigarette industry, withstood a motion to dismiss on Aug. 19, 2021.
While U.S. District Judge William H. Orrick granted a defense request to compel the direct purchaser class’ three named representatives to arbitration, he allowed time for the class to substitute a proposed plaintiff whose claims would not be subject to arbitration. The remaining motions to dismiss were largely denied, however, allowing the class action to proceed in the Northern District of California. Read the order.
Motley Rice filed suit over these allegations in April 2020. Motley Rice antitrust attorney Michelle Clerkin is a member of the Plaintiffs’ Steering Committee for Direct Purchaser Plaintiffs.
Formerly Philip Morris, Altria is one of the world’s largest cigarette manufacturers. The company competed with JUUL for years as the second-leading manufacturer of e-cigarettes, but later abandoned its e-cigarette production efforts in 2018 after buying a 35% share of JUUL. The $12.8 billion deal made Altria JUUL’s largest investor.
No longer competitors, JUUL and Altria’s mutually beneficial deal secured JUUL’s place as the nation’s leading e-cigarette manufacturer and allegedly removed incentives to keep prices in check, harming consumers. The deal constituted an “unreasonable restraint of trade” in violation of federal antitrust laws, the Federal Trade Commission stated in a press release on April 2020 that announced its filing of an administrative complaint against both companies. The case is scheduled to go to trial in January 2021. The FTC’s trial against JUUL and Altria began June 2021 and is ongoing.
Motley Rice filed the first direct purchaser claim in the civil class action in the country, Reece v. Altria Group Inc. et al., for consumers who were impacted by JUUL and Altria’s alleged anticompetitive conduct. You may read the complaint here.
Our antitrust attorneys have extensive experience litigating numerous antitrust cases across a variety of industries and trade practices. The firm played an active role in resolving two of the largest U.S. multi-billion dollar antitrust settlements since the Sherman Act was enacted, In re NASDAQ Market-Makers Antitrust Litigation and In re Visa Check/Mastermoney Antitrust Litigation. Motley Rice also represents the largest retailer class representative in the $5.5 billion MasterCard MDL, In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation, MDL 1720, which is currently pending on appeal. The firm also represents consumers, union health and welfare plans, and health insurers in several generic drug antitrust litigation cases.
The Wall Street Journal (June 2, 2021): Altria-Juul Deal Goes to Trial Law360 (April 7, 2020): Altria, Juul Face Consumer Antitrust Action Over $12.8B DealAP News (April 2, 2020): Feds seek breakup of Altria-Juul deal on antitrust groundsBloomberg (Dec. 20, 2018): Altria Invests $12.8 Billion in E-Cigarette Maker Juul
Connect with an Attorney1.800.768.4026
Call us or fill out our online form with the details of your potential case.
Our team reviews your information to assess your potential case.
Talk with us about next steps.